Molecular and immune characteristics for lung adenocarcinoma patients with CMTM6 overexpression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular and immune characteristics for lung adenocarcinoma patients with CMTM6 overexpression

Published:2020-06 Issue: Volume:83 Page:106478
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Wang Hui,Gao Jinping,Zhang Renfeng,Li Meng,Peng Zhongmin,Wang Haiyong

Funder

Taishan Scholars Project

Academic Promotion Programme of Shandong First Medical University

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference41 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

2. Non-small-cell lung cancers: a heterogeneous set of diseases;Chen;Nat. Rev. Cancer,2014

3. Comment on “Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Cancers-A Meta-analysis“;Chen;Ann. Surg.,2019

4. Nonintubated uniportal VATS pulmonary anatomical resections;Galvez;J. Vis. Surg.,2017

5. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society);Couñago;Lung Cancer,2018

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Advances in the Study of CMTM6, a Focus on Its Novel Non-Canonical Cellular Locations, and Functions beyond Its Role as a PD-L1 Stabilizer;Cancers;2024-09-11

2. New link between RNH1 and E2F1: regulates the development of lung adenocarcinoma;BMC Cancer;2024-05-24

3. CMTM6: A Critical Prognostic Indicator in Non-Small Cell Lung Cancer;Journal of Cancer;2024

4. METTL3‐mediated m⁶A methylation of TRAF5 inhibits lung adenocarcinoma cell metastasis via activation of the PI3K/AKT/NF‐κB signaling pathway;The Kaohsiung Journal of Medical Sciences;2023-12-13

5. Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer;European Journal of Pharmacology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3